Literature DB >> 20647827

Aspirin is indicated for primary prevention of cardiovascular events in HIV-infected patients.

Carlos Tornero, Ana Ventura, Maricarmen Mafe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20647827     DOI： 10.1097/QAI.0b013e3181d913fd

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  8 in total

1.  Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care.

Authors:  Virginia A Triant; Steven K Grinspoon
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

Review 2.  Cardiovascular disease and HIV infection.

Authors:  Virginia A Triant
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

Review 3.  Prevention of stroke in people living with HIV.

Authors:  Ivy Nguyen; Anthony S Kim; Felicia C Chow
Journal:  Prog Cardiovasc Dis       Date:  2020-01-31       Impact factor: 8.194

4.  HIV stroke risk: evidence and implications.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah L Commins; William Yong; Margrit Carlson
Journal:  Ther Adv Chronic Dis       Date:  2013-03       Impact factor: 5.091

5.  Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients.

Authors:  Greer A Burkholder; Ashutosh R Tamhane; Jorge L Salinas; Michael J Mugavero; James L Raper; Andrew O Westfall; Michael S Saag; James H Willig
Journal:  Clin Infect Dis       Date:  2012-08-31       Impact factor: 9.079

6.  Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.

Authors:  Giuseppe Vittorio De Socio; Elena Ricci; Giustino Parruti; Leonardo Calza; Paolo Maggi; Benedetto Maurizio Celesia; Giancarlo Orofino; Giordano Madeddu; Canio Martinelli; Barbara Menzaghi; Lucia Taramasso; Giovanni Penco; Laura Carenzi; Marco Franzetti; Paolo Bonfanti
Journal:  Infection       Date:  2016-04-05       Impact factor: 3.553

7.  Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients.

Authors:  Sujit Suchindran; Susan Regan; James B Meigs; Steven K Grinspoon; Virginia A Triant
Journal:  Open Forum Infect Dis       Date:  2014-10-20       Impact factor: 3.835

8.  Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders.

Authors:  Helene C Blanchard; Ameer Y Taha; Stanley I Rapoport; Zhi-Xin Yuan
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2015-01-13       Impact factor: 4.006
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.